Risks of whole brain radiation therapy added to radiosurgery outweigh benefits for patients with limited brain metastases
MD Anderson News Release 05/31/2015
Abstract LBA4
Whole Brain Radiation Therapy (WBRT) is associated with significantly worse cognitive function than radiosurgery, and should no longer be used in the adjuvant setting after radiosurgery to treat cancer patients with brain metastases, according to a large study led by a researcher at The University of Texas MD Anderson Cancer Center.
MD Anderson’s Paul Brown, M.D.,...
Study identifies possible new combination chemotherapy for patients with advanced prostate cancer
MD Anderson News Release 05/30/2015
For more than a decade, oncologists using cytotoxic chemotherapy to treat patients with advanced...
ASCO honors Allison for achievements in cancer immunotherapy
MD Anderson News Release 05/29/2015
The world’s leading organization of oncologists will honor Jim Allison, Ph.D., for his pioneering...
MD Anderson receives $9 million in CPRIT research funding
MD Anderson News Release 05/21/2015
The University of Texas MD Anderson Cancer Center has received more than $9 million in research grants in the latest round of funding from the Cancer Prevention and Research Institute of Texas (CPRIT). The grants were announced Wednesday, May 20. Full details can be found here.
The awards will fund studies in colorectal cancer, head and neck cancers and precision oncology decision...
Study Finds Biomarker May Boost Ovarian Cancer Chemotherapy Response
MD Anderson News Release 05/20/2015
A molecule that helps control gene expression may play a role in controlling chemotherapy...
MD Anderson Making Cancer History® Seminar in Austin rescheduled for June 16
Experts to reveal latest knowledge in personalized therapy and cancer prevention at second annual, free lunch event
MD Anderson News...
Variations in liver cancer attributable to hepatitis virus variations
Discovery that hepatitis B and C viruses generate markedly different clinical pathologies highlights potential change in treatment plans for...
Stereotactic Ablative Radiotherapy achieves better overall survival than surgery for early lung cancer
First randomized clinical trial comparing the two therapies suggests that the non-invasive SABR treatment should be considered an alternative...
Protein FGL2 May Have Potential as Therapy Target for Brain Cancer
MD Anderson News Release 05/13/2015
Blocking FGL2, a protein known to promote cancer, may offer a new strategy for treating brain...
Tumor sequencing study highlights benefits of profiling healthy tissue as well
MD Anderson study identifies harmful inherited mutations; explores sharing this information with patients and families
MD Anderson...